ofloxacin and rokitamycin

ofloxacin has been researched along with rokitamycin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	5 (71.43)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Machii, A; Nitta, Y; Obana, M; Ota, S; Sagara, H; Sato, J; Seo, T; Takizawa, Y; Tomizawa, I; Tsunoda, T	1
Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K	1
Hirai, K; Hiramatsu, K; Kishi, K; Murakami, J; Nasu, M; Yamasaki, T	1
De Vecchi, E; Drago, L; Gismondo, MR; Lombardi, A; Nicola, L; Valli, M	1
Hiramatsu, K; Hirata, N; Kadota, J; Kishi, K; Murakami, J; Nasu, M; Shibata, T; Yamasaki, T	1
Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A	1

Trials

1 trial(s) available for ofloxacin and rokitamycin

Article	Year
[Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1991, Volume: 65, Issue:9 Topics: Adolescent; Adult; Aged; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Double-Blind Method; Enteritis; Female; Humans; Male; Middle Aged; Miocamycin; Ofloxacin	1991

Article

Year

[Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1991, Volume: 65, Issue:9

Topics: Adolescent; Adult; Aged; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Double-Blind Method; Enteritis; Female; Humans; Male; Middle Aged; Miocamycin; Ofloxacin

1991

Other Studies

6 other study(ies) available for ofloxacin and rokitamycin

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. Journal of periodontal research, 1995, Volume: 30, Issue:4 Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline	1995
Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro. International journal of antimicrobial agents, 2000, Volume: 15, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cefdinir; Cephalosporins; Chlorocebus aethiops; Clindamycin; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Humans; Latex Fixation Tests; Levofloxacin; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Roxithromycin; Shiga Toxin 1; Shiga Toxin 2; Time Factors; Vero Cells	2000
Bactericidal activity of levofloxacin, gatifloxacin, penicillin, meropenem and rokitamycin against Bacillus anthracis clinical isolates. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:6 Topics: Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Penicillins; Thienamycins	2002
Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection. International journal of antimicrobial agents, 2003, Volume: 21, Issue:5 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Colony Count, Microbial; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Feces; Levofloxacin; Male; Mice; Mice, Inbred C3H; Miocamycin; Ofloxacin; Survival Analysis	2003
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials. Pharmacoepidemiology and drug safety, 2005, Volume: 14, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors	2005